PubMed Health⌕ Search

PubMed · 2644603

Acyclovir therapy during pregnancy.

Abstract

Although there are as yet no established indications for acyclovir use in pregnancy, the most reasonable uses are for maternal infections such as disseminated herpes simplex, varicella pneumonia, and severe primary genital herpes. Other potential, but more problematic, uses during pregnancy are for uncomplicated primary genital herpes infections, maternal varicella, and for prophylaxis against the recurrence of genital herpes near term. We review each of these potential uses and the pharmacokinetics of acyclovir in pregnancy while emphasizing that at the present time, safety, efficacy, and appropriate dosage of the drug have not been established for any use in pregnancy.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Z A Brown, D A Baker. 1989. Acyclovir therapy during pregnancy.. https://pubmed.ncbi.nlm.nih.gov/2644603/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Synthesis, DNA binding and antiviral activity of new uracil, xanthine, and pteridine derivatives.

Some new 6-amino-1,3-dimethyl-5-(substituted methylidene)aminouracils were synthesized. Most of them were cyclized with triethyl orthoformate as a one-carbon source to afford 1,3-dime-thyl-6-substituted pteridine derivatives. Certain uracils gave xanthine instead of the expected pteridine derivatives upon using another one-carbon source such as triethyl orthoacetate or triethyl orthobenzoate. The nucleic acid binding assay revealed that some new compounds showed high affinity, chelation, and fragmentation of nucleic acids whether DNA or RNA contrary to acyclovir that has affinity to DNA only. The antiviral activity of these novel compounds showed that compounds 2e and 2f reduced the cytopathogencity of Peste des petits ruminant virus (PPRV) on Vero cell culture by 60 and 50%, respectively.

Acyclovir↗